安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Welcome to Cordis
Cordis is a global leader in delivering innovative, differentiated cardiovascular and endovascular devices For over 60 years, we’ve pioneered products
- What Is The Difference Between A Cordis And Central Line?
What is the difference between a Cordis and central line? This “ introducer ” can be used as an additional central line regardless of whether a catheter is inserted through the centre The introducer is often called the “Cordis”; this was the Trade name for the first product ever produced …
- Cordis (medical) - Wikipedia
Cordis is an American international medical company that develops and manufactures medical devices for diagnostics and interventional procedures to treat coronary and peripheral vascular diseases
- CORDIS | European Commission
Welcome to CORDIS, where you can access comprehensive information about EU Research Development projects Whether you're a researcher, innovator, or just curious, here you'll find information on projects, topics, and publications funded by the EU's research programs - in multiple languages
- What Is a Cordis Catheter and How Is It Used? - ScienceInsights
A Cordis catheter is a large-bore introducer sheath used to create a temporary gateway into a major blood vessel The name “Cordis” comes from the manufacturer (now part of Cardinal Health), but the term has become shorthand in hospitals for any catheter sheath introducer of this type
- Cordis
Global Preferences: To continue, select settings and agree to the Terms Of Use
- Cordis | emerging
Cordis is a worldwide leader in the development and manufacture of interventional vascular technology with a more than 50-year history of delivering pioneering products to treat millions of patients
- Cardinal Health Completes Sale of Cordis Business to Hellman Friedman
Cardinal Health (NYSE: CAH), Dublin, Ohio, on Monday announced it has completed the previously announced sale of Cardinal Health’s Cordis business to Hellman Friedman for $1 billion “We appreciate H F’s partnership throughout the transaction, and we are excited about Cordis’s future under H F’s ownership,” said Mike Kaufmann, CEO of Cardinal Health “As we shared previously
|
|
|